Abstract
Predictive analytics tools variably take into account data from the electronic medical record, lab tests, nursing charted vital signs and continuous cardiorespiratory monitoring data to deliver an instantaneous score that indicates patient risk or instability. Few, if any, of these tools reflect the risk to a patient accumulated over the course of an entire hospital stay. This approach fails to best utilize all of the collated data regarding the risk or instability sustained by the patient, and hence fails to fully characterize this to optimize the ability of treating clinicians to maximize the chances of a favorable outcome. We have built on our instantaneous CoMET predictive analytics score to generate the cumulative CoMET score (cCOMET), which sums all of the instantaneous CoMET scores throughout a hospital admission relative to a baseline expected risk unique to that patient. We have shown that higher cCOMET scores predict mortality, but not length of stay, and that higher baseline CoMET scores predict higher cCoMET scores at discharge/death. cCoMET scores were higher in males in our cohort, and added information to the final CoMET when it came to the prediction of death. In summary, if one is going to go to the trouble and expense of performing repeated measures when performing predictive analytics calculations, we have shown that including all of these measures in a cumulative way adds data to instantaneous predictive analytics, and could improve the ability of clinicians to predict deterioration, and improve patient outcomes in so doing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded in part by a philanthropic donation through the Frederick Thomas fund at the University of Virginia
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Virginia gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing interests: DEL and JRM own stock in Medical Predictive Science Corporation, Charlottesville, VA; JRM is a consultant for Nihon Kohden Digital Health Solutions, Irvine, CA.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
